Arch Therapeutics, Inc.
Arch Therapeutics, Inc. |
Richard King |
4:2025bk40409 |
April 18, 2025 |
U.S. Bankruptcy Court for the District of Massachusetts |
Elizabeth D Katz |
Other |
Docket Report
This docket was last retrieved on June 9, 2025. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 99 Certificate of Service re Notice of Bar Dates and Procedures for Filing Proofs of Claim (Re: #98 Order on Motion To Set Bar Date) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
![]() |
Filing 97 Endorsed Order dated 6/6/2025 Re: #96 Motion filed by Debtor Arch Therapeutics, Inc. for Order (I) Establishing Bar Dates for Filing Proofs of Claim, and (II) Approving Form and Manner of Notice Thereof. THE DEBTORS ARE ORDERED TO SUBMIT A REVISED FORM OF PROPOSED ORDER AND NOTICE FORTHWITH THAT CONTAINS THE INFORMATION INCLUDED IN PARAGRAPH 3 OF OFFICIAL LOCAL FORM 5. (pf) |
Filing 96 Motion filed by Debtor Arch Therapeutics, Inc. for Order (I) Establishing Bar Dates for Filing Proofs of Claim, and (II) Approving Form and Manner of Notice Thereof with certificate of service and proposed order. (Braunstein, Alan) |
Filing 95 Endorsed Order dated 6/2/2025 Re: #93 Notice of Amended Creditor Matrix filed by Debtor Arch Therapeutics, Inc. ALLOWED. (pf) |
Filing 94 Verification of Creditor Matrix (Re: #93 Amended Schedules-Creditor Matrix) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 93 Amended Schedule(s) Matrix with certificate of service Fee Amount $34 (Re: #11 Matrix) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 92 Declaration Concerning Debtor`s Schedules (Re: #91 Amended Schedules-Creditor Matrix) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 91 Amended Schedule(s) G with certificate of service (Re: #72 Schedules A-J) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Receipt of filing fee for Amended Schedules-Creditor Matrix(# 25-40409) [misc,amdsch] ( 34.00). Receipt Number A20981127, amount $ 34.00 (re: Doc#93) (U.S. Treasury) |
Filing 90 Certificate of Service (Re: #86 Notice of Intent to Sell, #87 Amended Document) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 89 Certificate of Service (Re: #86 Notice of Intent to Sell, #87 Amended Document) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 88 Certificate of Service (Re: #84 Order To Set Hearing, #85 Exhibit) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 87 Amended Notice of (I) Proposed Sale of Assets of the Debtors Free and Clear of Any and All Liens, Claims and Encumbrances, (II) Deadline and Procedures for Submitting Objections and Higher Offers, (III) Assumption and Assignment of Certain Prepetition Agreement, and (IV) Sale Hearing Date (Re: #85 Exhibit) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Meeting of Creditors Held and Examination of Debtor and concluded on May 28, 2025. (Bradford, Eric) |
Filing 86 Notice of Intent to Sell PURCHASED ASSETS. Hearing scheduled for 6/20/2025 at 11:00 AM at Worcester Courtroom 3 and by Zoom.gov Videoconference Re: #65 Expedited Motion filed by Debtor Arch Therapeutics, Inc. for an Order (A) Authorizing and Approving Sale and Bidding Procedures and Breakup Fee in Connection with Proposed Sale of the Debtor's Assets; (B) Scheduling a Hearing to Consider Approval of the Sale; (C) Prescribing the Manner of Notice for Such Hearing; (D) Authorizing and Approving Asset Purchase Agreement with the Proposed Buyer or Another Bidder Providing a Higher or Better Offer; (E) Authorizing Such Sale Free and Clear of All Liens, Claims, Encumbrances, and Other Interests; (F) Approving the Assumption and Assignment of Certain Prepetition Agreement; and (G) Granting Other Related Relief. Objections and Bids/Counterofffers due by 6/17/2025 at 04:30 PM. (pf) |
Filing 85 Exhibit Notice of (I) Proposed Sale of Assets of the Debtors Free and Clear of Any and All Liens, Claims and Encumbrances, (II) Deadline and Procedures for Submitting Objections and Higher Offers, (III) Assumption and Assignment of Certain Prepetition Agreement, and (IV) Sale Hearing Date (Re: #65 Motion to Sell) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
![]() |
Filing 83 Final Order dated 5/27/2025 Re: #10 Amended #3 Motion filed by Debtor Arch Therapeutics, Inc. for Entry of Interim Orders (I) Authorizing Debtors to (A) Obtain Postepetition Secured Financing Pursuant to Section 364 of the Bankruptcy Code, (B) Use Cash Collateral, (II) Granting Liens and Superpriority Administrative Expense Status, (III) Granting Adewquate Protection, (IV) Modifying the Automatic Stay, (V) Scheduling a Final Hearing, and (VI) Granting Related Relief. GRANTED. See Order for Full Text. (pf) |
Filing 82 Proceeding Memorandum and Order dated 5/23/2025 Re: #65 Expedited Motion filed by Debtor Arch Therapeutics, Inc. for an Order (A) Authorizing and Approving Sale and Bidding Procedures and Breakup Fee in Connection with Proposed Sale of the Debtor's Assets; (B) Scheduling a Hearing to Consider Approval of the Sale; (C) Prescribing the Manner of Notice for Such Hearing; (D) Authorizing and Approving Asset Purchase Agreement with the Proposed Buyer or Another Bidder Providing a Higher or Better Offer; (E) Authorizing Such Sale Free and Clear of All Liens, Claims, Encumbrances, and Other Interests; (F) Approving the Assumption and Assignment of Certain Prepetition Agreement; and (G) Granting Other Related Relief. DEBTOR'S COUNSEL IS DIRECTED TO SUBMIT TO EDK@MAB.USCOURTS.GOV A PROPOSED ORDER, IN WORD FORMAT, CONSISTENT WITH THE REMARKS MADE DURING THE HEARING HELD THIS DATE. (pf) |
Filing 81 Proceeding Memorandum and Order dated 5/23/2025 Re: #10 Amended #3 Motion filed by Debtor Arch Therapeutics, Inc. for Entry of Interim Orders (I) Authorizing Debtors to (A) Obtain Postepetition Secured Financing Pursuant to Section 364 of the Bankruptcy Code, (B) Use Cash Collateral, (II) Granting Liens and Superpriority Administrative Expense Status, (III) Granting Adewquate Protection, (IV) Modifying the Automatic Stay, (V) Scheduling a Final Hearing, and (VI) Granting Related Relief. THE DEBTOR'S USE OF CASH COLLATERAL IS AUTHORIZED ON A FINAL BASIS. DEBTOR'S COUNSEL IS DIRECTED TO SUBMIT TO EDK@MAB.USCOURTS.GOV A PROPOSED ORDER, IN WORD FORMAT, CONSISTENT WITH THE REMARKS MADE DURING THE HEARING HELD THIS DATE. (pf) |
Filing 80 Proceeding Memorandum and Order dated 5/23/2025 Re: #1 Voluntary Petition (Chapter 11) filed by Debtor Arch Therapeutics, Inc. STATUS CONFERENCE HELD. (pf) |
Hearing Held Re: #65 Expedited Motion filed by Debtor Arch Therapeutics, Inc. for an Order (A) Authorizing and Approving Sale and Bidding Procedures and Breakup Fee in Connection with Proposed Sale of the Debtor's Assets; (B) Scheduling a Hearing to Consider Approval of the Sale; (C) Prescribing the Manner of Notice for Such Hearing; (D) Authorizing and Approving Asset Purchase Agreement with the Proposed Buyer or Another Bidder Providing a Higher or Better Offer; (E) Authorizing Such Sale Free and Clear of All Liens, Claims, Encumbrances, and Other Interests; (F) Approving the Assumption and Assignment of Certain Prepetition Agreement; and (G) Granting Other Related Relief. (pf) |
Hearing Held Re: #10 Amended #3 Motion filed by Debtor Arch Therapeutics, Inc. for Entry of Interim Orders (I) Authorizing Debtors to (A) Obtain Postepetition Secured Financing Pursuant to Section 364 of the Bankruptcy Code, (B) Use Cash Collateral, (II) Granting Liens and Superpriority Administrative Expense Status, (III) Granting Adewquate Protection, (IV) Modifying the Automatic Stay, (V) Scheduling a Final Hearing, and (VI) Granting Related Relief. (pf) |
Status Conference Held Re: #1 Voluntary Petition (Chapter 11) filed by Debtor Arch Therapeutics, Inc. (pf) |
Filing 79 Notice of Revised Proposed Final DIP Order and Exhibits (Re: #78 Notice) filed by Debtor Arch Therapeutics, Inc. (Attachments: #1 Exhibit A (Revised Proposed Final DIP Order) #2 Exhibit B (Redline fo Revised Proposed Final DIP Order Against Interim DIP Order [Doc. No. 57] #3 Exhibit C (Incremental Redline (Changed Pages Only) of Revised Proposed Final DIP Order Against Proposed Final DIP Order filed at Docket No. 78) #4 Exhibit D (Proposed DIP Credit Agreement (Exhibit 1 to Revised Proposed Final DIP Order) #5 Exhibit E (Approved Budget [Exhibit 2 to Revised Proposed DIP Order]) #6 Certificate of Service) (Braunstein, Alan) |
Filing 78 Notice of Proposed Final DIP Order with certificate of service (Re: #10 Motion to Refinance/Incur Debt/Obtain Credit) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 77 Objection (With Certificates of Service and Conference) filed by Assistant U.S. Trustee Richard King Re: #65 Expedited Motion filed by Debtor Arch Therapeutics, Inc. for Sale of Property free and clear of liens under Section 363(f) Re: for an Order (A) Authorizing and Approving Sale and Bidding Procedures and Breakup Fee in Connection with Proposed Sale of (Bradford, Eric) |
Filing 76 Endorsed Order dated 5/22/2025 Re: #75 Assented to Motion filed by Assistant U.S. Trustee Richard King to Extend Time to File Objection [Re: #65 Motion to Sell]. GRANTED IN PART. THE DEADLINE FOR THE TRUSTEE IS EXTENDED TO MAY 22, 2025 AT 4:30 PM. (pf) |
Filing 75 Assented to Motion filed by Assistant U.S. Trustee Richard King to Extend Time to File Objection [Re: #65 Motion to Sell] with certificate of service. (Bradford, Eric) |
Filing 74 Notice of Appearance and Request for Notice on Behalf of William K. Harrington, United States Trustee for Region 1 by Eric K. Bradford with certificate of service filed by Assistant U.S. Trustee Richard King (Bradford, Eric) |
![]() |
Filing 72 Schedules A through H. filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 71 Statement of Financial Affairs for Non-Individual filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 70 Equity Security Holders (Re: #16 Order to Update) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 69 Certificate of Service of Notice of Hearing (Re: #65 Motion to Sell, #66 Order To Set Hearing) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 68 Certificate of Service of Notice of Hearing (Re: #1 Voluntary Petition (Chapter 11), #10 Motion to Refinance/Incur Debt/Obtain Credit, #22 Order To Set Hearing, #64 Order on Motion to Continue/Cancel Hearing) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 67 Certificate of Service (Re: #65 Motion to Sell) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
![]() |
Filing 65 Expedited Motion filed by Debtor Arch Therapeutics, Inc. for an Order (A) Authorizing and Approving Sale and Bidding Procedures and Breakup Fee in Connection with Proposed Sale of the Debtor's Assets; (B) Scheduling a Hearing to Consider Approval of the Sale; (C) Prescribing the Manner of Notice for Such Hearing; (D) Authorizing and Approving Asset Purchase Agreement with the Proposed Buyer or Another Bidder Providing a Higher or Better Offer; (E) Authorizing Such Sale Free and Clear of All Liens, Claims, Encumbrances, and Other Interests; (F) Approving the Assumption and Assignment of Certain Prepetition Agreement; and (G) Granting Other Related Relief . Fee Amount $199 (Attachments: #1 Exhibit 1 (Sale and Bidding Procedures) #2 Exhibit A (Stalking Horse Asset Purchase Agreement) #3 Exhibit B (Proposed Bid Procedures Order) #4 Exhibit C (Proposed Sale Order) #5 Exhibit D (Form Sale Notice)) (Braunstein, Alan) |
Receipt of filing fee for Motion to Sell(# 25-40409) [motion,msell] ( 199.00). Receipt Number A20959955, amount $ 199.00 (re: Doc#65) (U.S. Treasury) |
Filing 64 Endorsed Order dated 5/14/2025 Re: #62 Assented To Motion filed by Debtor Arch Therapeutics, Inc. to Continue Hearing [Re: Status Conference on #1 Voluntary Petition and #10 Amended Motion for Post-Petition Financing]. GRANTED; THE HEARING OF MAY 22, 2025 IS CONTINUED TO FRIDAY, MAY 23, 2025 AT 10:00 AM. THE HEARINGS WILL BE CONDUCTED BY ZOOM.GOV VIDEOCONFERENCE. TO ATTEND THE HEARING, BY 12:00 P.M. ONE COURT BUSINESS DAY BEFORE THE HEARING, EMAIL THE COURTROOM CLERK AT STEPHEN_REYNOLDS@MAB.USCOURTS.GOV REQUESTING REMOTE PARTICIPATION AND PROVIDE YOUR NAME, THE PARTY YOU REPRESENT, AND WHETHER OR NOT YOU WILL BE AN ACTIVE PARTICIPANT IN THE HEARING OR ONLY OBSERVING. PARTICIPATION BY VIDEO IS ONLY PERMITTED BY PARTIES IN INTEREST. MEMBERS OF THE GENERAL PUBLIC, INCLUDING THE PRESS, WILL BE PERMITTED TO ATTEND THE HEARING EXCLUSIVELY BY AUDIO. (pf) |
Hearing Continued to 05/23/2025 at 10:00 AM at a Zom.gov Videoconference Re: #10 Amended Motion of Debtor for Entry of Interim Orders (I) Authorizing Debtors to (A) Obtain Postepetition Secured Financing Pursuant to Section 364 of the Bankruptcy Code, (B) Use Cash Collateral, (II) Granting Liens and Superpriority Administrative Expense Status, (III) Granting Adequate Protection, (IV) Modifying the Automatic Stay, (V) Scheduling a Final Hearing, and (VI) Granting Related Relief. (pf) |
Hearing Continued to 05/23/2025 at 10:00 AM at a Zoom.gov Videoconference Re: Status Conference on #1 Voluntary Petition (Chapter 11) Filed by Debtor Arch Therapeutics, Inc. (pf) |
Filing 63 BNC Certificate of Mailing - Meeting of Creditors. (Re: #61 Court's Notice of 341 sent - 11 Corporation) Notice Date 05/09/2025. (Admin.) |
Filing 62 Assented To Motion filed by Debtor Arch Therapeutics, Inc. to Continue Hearing [Re: Status Conference on #1 Voluntary Petition and #10 Amended Motion for Post-Petition Financing] Scheduled for May 22, 2025 with certificate of service. (Braunstein, Alan) |
Telephonic Meeting Information for Section 341 Meeting of Creditors: Dial-in Number: 877.716.4195 Participant Code: 3585070#. For International Call Information Please Contact the Trustee. (Meunier, Stephen) |
Filing 61 Court's Notice of 341 sent. (pf) |
Meeting of Creditors. 341(a) meeting to be held on 5/28/2025 at 02:30 PM as a Telephonic Meeting. (pf) |
Filing 60 Notice of Hearing (HYBRID) and Objection Deadline (Re: #10 Motion to Refinance/Incur Debt/Obtain Credit) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 59 Disclosure of Compensation of Attorney Alan L. Braunstein in the amount of $100,000.00. Plus $3,476.00 paid to debtor`s counsel for court filing fees filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 58 Endorsed Order dated 5/2/2025 Re: #55 Emergency Motion filed by Debtor Arch Therapeutics, Inc. to Authorize Payment of Insurance in the Amount of $36,666.50. GRANTED. SEE ORDER OF EVEN DATE ON DOCKET #10 (THE "MOTION TO APPROVE DIP FINANCING"). THE HEARING ON THE MOTION TO APPROVE DIP FINANCING SET FOR MAY 5, 2025 IS CANCELED AND A FINAL HEARING ON THE MOTION FOR DIP FINANCING HAS BEEN SET FOR MAY 22, 2025. (pf) |
Filing 57 Interim Order dated 5/2/2025 #10 Authorizing Debtors to (A) Obtain Postepetition Secured Financing Pursuant to Section 364 of the Bankruptcy Code, (B) Use Cash Collateral, (II) Granting Liens and Superpriority Administrative Expense Status, (III) Granting Adequate Protection, (IV) Modifying the Automatic Stay, (V) Scheduling a Final Hearing, and (VI) Granting Related Relief. The Final Hearing on the Motion shall be held on May 22, 2025 at 12:00 PM both in person at the Federal Courthouse, Berkshire Courtroom, 300 State Street, Springfield, MA and by Zoom.gov Videoconference. See Order for Full Text. (pf) |
Filing 56 Notice of Further Amended Documents (Re: #49 Notice) filed by Debtor Arch Therapeutics, Inc. (Attachments: #1 Exhibit A (Second Amended Proposed Interim Order w/Exhibits) #2 Exhibit B (Redlined Amended Proposed DIP Order) #3 Exhibit C (Redlined Amended DIP Term Sheet) #4 Exhibit D (Redlined DIP Budget)) (Braunstein, Alan) |
Filing 55 Emergency Motion filed by Debtor Arch Therapeutics, Inc. For Authority for Payment of Insurance in the Amount of $36,666.50. (Braunstein, Alan) |
Hearing Continued to 05/22/2025 at 12:00 PM at Springfield Courtroom - Berkshire and by Zoom.gov Videoconference Re: #10 Amended Motion of Debtor for Entry of Interim Orders (I) Authorizing Debtors to (A) Obtain Postepetition Secured Financing Pursuant to Section 364 of the Bankruptcy Code, (B) Use Cash Collateral, (II) Granting Liens and Superpriority Administrative Expense Status, (III) Granting Adequate Protection, (IV) Modifying the Automatic Stay, (V) Scheduling a Final Hearing, and (VI) Granting Related Relief. (pf) |
Filing 54 Certificate of Service (Re: #53 Order on Motion to Refinance/Incur Debt) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 53 Proceeding Memorandum and Order dated 4/29/2025 Re: #10 Amended Motion of Debtor for Entry of Interim Orders (I) Authorizing Debtors to (A) Obtain Postepetition Secured Financing Pursuant to Section 364 of the Bankruptcy Code, (B) Use Cash Collateral, (II) Granting Liens and Superpriority Administrative Expense Status, (III) Granting Adequate Protection, (IV) Modifying the Automatic Stay, (V) Scheduling a Final Hearing, and (VI) Granting Related Relief. THIS HEARING IS CONTINUED TO MAY 5, 2025 AT 2:30 PM; THE CONTINUED HEARING WILL BE CONDUCTED BY ZOOM.GOV VIDEO CONFERENCE. PARTIES IN INTEREST WHO WISH TO PARTICIPATE THROUGH ZOOM, BY 12:00 P.M. ONE COURT BUSINESS DAY BEFORE THE HEARING, SHOULD EMAIL THE COURTROOM CLERK AT STEPHEN_REYNOLDS@MAB.USCOURTS.GOV TO RECEIVE THE ZOOM LINK. (pf) |
Hearing Held and Continued to 05/05/2025 at 02:30 PM by Zoom.gov Videoconference Re: #10 Amended Motion of Debtor for Entry of Interim Orders (I) Authorizing Debtors to (A) Obtain Postepetition Secured Financing Pursuant to Section 364 of the Bankruptcy Code, (B) Use Cash Collateral, (II) Granting Liens and Superpriority Administrative Expense Status, (III) Granting Adequate Protection, (IV) Modifying the Automatic Stay, (V) Scheduling a Final Hearing, and (VI) Granting Related Relief. (pf) |
Filing 52 Certificate of Service (Re: #49 Notice) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 51 Certificate of Service (Re: #47 Motion to Extend Time) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
![]() |
Filing 49 Notice of Amended Documents (Re: #10 Motion to Refinance/Incur Debt/Obtain Credit) filed by Debtor Arch Therapeutics, Inc. (Attachments: #1 Exhibit A (Amended Proposed Interim Order) #2 Exhibit B (Amended DIP Term Sheet) #3 Exhibit C (Amended DIP Budget) #4 Exhibit D (Redlined Amended Proposed Interim Order) #5 Exhibit E (Redlined Amended DIP Term Sheet) #6 Exhibit F (Redlined DIP Budget)) (Braunstein, Alan) |
Filing 48 Endorsed Order dated 4/29/2025 Re: #47 Expedited Motion filed by Debtor Arch Therapeutics, Inc. to Extend Time to File Documents [Re: #16 Order to Update]. GRANTED. THE DEADLINE FOR FILING THE MISSING DOCUMENTS IS EXTENDED TO MAY 19, 2025. (pf) |
Receipt Number phv-21560-1745855117, Fee Amount $100.00 Re: #44 Notice of Fee Due (Pro Hac Vice) issued to Jeremy D. Lockhart representing Oasis Capital, LLC, Brandt Wilson and Mona Wilson Re: #43 Motion filed by Adrienne K Walker on behalf of Jeremy D. Lockhart to Appear pro hac vice. (sas) |
Filing 47 Expedited Motion filed by Debtor Arch Therapeutics, Inc. to Extend Time to File Documents [Re: #16 Order to Update]. (Braunstein, Alan) |
Filing 46 Request for a Hearing Audio File of April 24, 2025 Hearing Fee Amount $34 (Re: #3 Motion to Refinance/Incur Debt/Obtain Credit) filed by Creditor Vivex Biologics, Inc. (Bernardino, Colin) |
Filing 45 Supplemental Objection of Prepetition Secured Parties with certificate of service filed by Creditors Oasis Capital, LLC, Brandt Wilson, Mona Wilson Re: #10 Amended Debtors Motion for Entry of Interim and Final Orders (I) Authorizing Debtors to (A) Obtain Postpetition Secured Financing Pursuant to Section 364 of the Bankruptcy Code, (B) Use Cash Collateral, (II) Granting Liens and Superpriority Administrative Expense Status, (III) Granting Adequate Protection, (IV) Modifying the Automatic Stay, (V) Scheduling a Final Hearing, and (VI) Granting Related Relief (Attachments: #1 Exhibit A - Wilson Declaration) (Walker, Adrienne) |
Filing 44 Notice of Fee Due (Pro Hac Vice) issued to Jeremy D. Lockhart representing Oasis Capital, LLC, Brandt Wilson and Mona Wilson Re: #43 Motion filed by Adrienne K Walker on behalf of Jeremy D. Lockhart to Appear pro hac vice for Creditors Oasis Capital, LLC, Brandt Wilson and Mona Wilson. PHV Fee Due 5/8/2025. (pf) |
Filing 43 Motion filed by Adrienne K Walker on behalf of Jeremy D. Lockhart to Appear pro hac vice for Creditors Oasis Capital, LLC, Brandt Wilson, Mona Wilson. (Attachments: #1 Exhibit A #2 Proposed Order) (Walker, Adrienne) |
Receipt of filing fee for Request for Hearing Audio File(# 25-40409) [misc,reqaud] ( 34.00). Receipt Number A20936913, amount $ 34.00 (re: Doc#46) (U.S. Treasury) |
Filing 42 BNC Certificate of Mailing - PDF Document. (Re: #39 Order on Motion to Appear pro hac vice) Notice Date 04/27/2025. (Admin.) |
Filing 41 BNC Certificate of Mailing - Notice (Re: #29 Court's Notice of Deficiency (POC)) Notice Date 04/26/2025. (Admin.) |
Filing 40 BNC Certificate of Mailing - PDF Document. (Re: #25 Order on Motion to Appear pro hac vice) Notice Date 04/25/2025. (Admin.) |
![]() |
![]() |
Filing 37 Request for a Hearing Audio File of April 24, 2025 Hearing Fee Amount $34 (Re: #3 Motion to Refinance/Incur Debt/Obtain Credit) filed by Creditors Oasis Capital, LLC, Brandt Wilson, Mona Wilson (Walker, Adrienne) |
Filing 36 Certificate of Service of Notice of Hearing (Re: #1 Voluntary Petition (Chapter 11), #22 Order To Set Hearing) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 35 Certificate of Service of Notice of Hearing (Re: #10 Motion to Refinance/Incur Debt/Obtain Credit, #34 Order on Motion to Refinance/Incur Debt) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 34 Proceeding Memorandum and Order dated 4/25/2025 Re: #10 Amended Motion of Debtor for Entry of Interim Orders (I) Authorizing Debtors to (A) Obtain Postepetition Secured Financing Pursuant to Section 364 of the Bankruptcy Code, (B) Use Cash Collateral, (II) Granting Liens and Superpriority Administrative Expense Status, (III) Granting Adequate Protection, (IV) Modifying the Automatic Stay, (V) Scheduling a Final Hearing, and (VI) Granting Related Relief. THIS HEARING IS CONTINUED TO APRIL 29, 2025 AT 12:30 PM; THE CONTINUED HEARING WILL BE CONDUCTED BY ZOOM.GOV VIDEO CONFERENCE. PARTIES IN INTEREST WHO WISH TO PARTICIPATE THROUGH ZOOM, BY 12:00 P.M. ONE COURT BUSINESS DAY BEFORE THE HEARING, SHOULD EMAIL THE COURTROOM CLERK AT STEPHEN_REYNOLDS@MAB.USCOURTS.GOV TO RECEIVE THE ZOOM LINK. (pf) |
Filing 33 Notice of Fee Due (Pro Hac Vice) issued to Glenn S. Walter representing Oasis Capital, LLC, Brandt Wilson and Mona Wilson. PHV Fee Due 5/5/2025. (Re: #31 Motion filed by Adrienne K Walker on behalf of Glenn S. Walterto Appear pro hac vice filed by Creditors Oasis Capital, LLC, Brandt Wilson and Mona Wilson). (pf) |
Filing 32 Notice of Fee Due (Pro Hac Vice) issued to Scott B. Kitei representing Oasis Capital, LLC, Brandt Wilson and Mona Wilson. PHV Fee Due 5/5/2025. (Re: #30 Motion to Appear pro hac vice filed by Creditors Oasis Capital, LLC, Brandt Wilson and Mona Wilson). (pf) |
Receipt of filing fee for Request for Hearing Audio File(# 25-40409) [misc,reqaud] ( 34.00). Receipt Number A20934308, amount $ 34.00 (re: Doc#37) (U.S. Treasury) |
Receipt Number phv-76082-1745539271, Fee Amount $100.00 Re: #32 Notice of Fee Due (Pro Hac Vice) issued to Scott B. Kitei representing Oasis Capital, LLC, Brandt Wilson and Mona Wilson (Re: #30 Motion to Appear pro hac vice filed by Creditors Oasis Capital, LLC, Brandt Wilson and Mona Wilson). (sas) |
Receipt Number phv-82556-1745539597, Fee Amount $100.00 Re: #33 Notice of Fee Due (Pro Hac Vice) issued to Glenn S. Walter representing Oasis Capital, LLC, Brandt Wilson and Mona Wilson (Re: #31 Motion filed by Adrienne K Walker on behalf of Glenn S. Walterto Appear pro hac vice filed by Creditors Oasis Capital, LLC, Brandt Wilson and Mona Wilson). (sas) |
Hearing Held and Continued to 04/29/2025 at 12:30 PM by Zoom.gov Videoconference Re: #10 Amended Motion of Debtor for Entry of Interim Orders (I) Authorizing Debtors to (A) Obtain Postepetition Secured Financing Pursuant to Section 364 of the Bankruptcy Code, (B) Use Cash Collateral, (II) Granting Liens and Superpriority Administrative Expense Status, (III) Granting Adequate Protection, (IV) Modifying the Automatic Stay, (V) Scheduling a Final Hearing, and (VI) Granting Related Relief. (pf) |
Filing 31 Motion filed by Adrienne K Walker on behalf of Glenn S. Walter to Appear pro hac vice for Creditors Oasis Capital, LLC, Brandt Wilson, Mona Wilson. (Attachments: #1 Exhibit A #2 Proposed Order) (Walker, Adrienne) |
Filing 30 Motion filed by Adrienne K Walker on behalf of Scott B. Kitei to Appear pro hac vice for Creditors Oasis Capital, LLC, Brandt Wilson, Mona Wilson. (Attachments: #1 Exhibit A #2 Proposed Order) (Walker, Adrienne) |
Filing 29 Court's Notice of Deficiency (POC) to Broadridge Financial Solutions Re: Proof of Claim 2. (lc) |
Filing 28 Objection filed by Creditors Oasis Capital, LLC, Brandt Wilson, Mona Wilson Re: #10 Amended Motion filed by Debtor Arch Therapeutics, Inc. to Obtain Credit Under Section 364 Postpetition Secured Financing Pursuant to Section 364 and Granting Liens and Superpriority Administrative Expense with Vivex Biologics, Inc.. (Attachments: #1 Exhibit Proposed Budget #2 Exhibit DIP Financing Term Sheet) (Walker, Adrienne) |
Filing 27 Notice of Appearance and Request for Notice of Appearance by Adrienne K Walker filed by Creditors C/M Capital Partners LP, Andrew Stahl, District2 Capital Fund LP, Bigger Capital, LLC, Mona Wilson, Brandt Wilson, Oasis Capital, LLC (Walker, Adrienne) |
Filing 26 Notice of Appearance and Request for Notice by Colin M Bernardino filed by Creditor Vivex Biologics, Inc. (Bernardino, Colin) |
Filing 25 Endorsed Order dated 4/23/2025 Re: #23 Motion filed by Colin M. Bernardino for Admission Pro Hac Vice for Creditor Vivex Biologics, Inc. GRANTED. (pf) |
Filing 24 Notice of Fee Due (Pro Hac Vice) issued to Colin M. Bernardino representing Vivex Biologics, Inc. (Re: #23 Motion to Appear pro hac vice filed by Creditor Vivex Biologics, Inc.) PHV Fee Due 5/5/2025. (sas) |
Filing 23 Motion filed by Colin M. Bernardino for Admission Pro Hac Vice for Creditor Vivex Biologics, Inc. (sas) |
Receipt Number phv-41824-1745355885, Fee Amount $100.00 Re: #24 Notice of Fee Due (Pro Hac Vice) issued to Colin M. Bernardino representing Vivex Biologics, Inc. (Re: #23 Motion to Appear pro hac vice). (sas) |
![]() |
Filing 21 Exhibit A (Re: #1 Voluntary Petition (Chapter 11)) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 20 Certificate of Service (Re: #5 Application to Employ, #6 Motion for Joint Administration, #10 Motion to Refinance/Incur Debt/Obtain Credit) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 19 Certificate of Service (Re: #3 Motion to Refinance/Incur Debt/Obtain Credit, #4 Affidavit/Declaration) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 18 Certificate of Service of Notice of Hearing (Re: #10 Motion to Refinance/Incur Debt/Obtain Credit, #17 Order To Set Hearing) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
![]() |
![]() |
Filing 15 Notice of Appearance and Request for Notice by Lisa D. Tingue with certificate of service filed by Assistant U.S. Trustee Richard King (Tingue, Lisa) |
![]() |
Filing 13 Endorsed Order dated 4/21/2025 Re: #3 Expedited Motion filed by Debtor Arch Therapeutics, Inc. to Obtain Credit Under Section 364 Obtain Postpetition Secured Financing Pursuant to Section 364 and Granting Liens and Superpriority Administrative Expense with Vivex Biologics, Inc. MOOT. SEE AMENDED MOTION [DOCKET #10] FILED APRIL 21, 2025. (ag) |
Filing 12 Verification of Creditor Matrix (Re: #11 Matrix) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 11 Matrix filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 10 Amended #3 Motion filed by Debtor Arch Therapeutics, Inc. for Entry of Interim Orders (I) Authorizing Debtors to (A) Obtain Postepetition Secured Financing Pursuant to Section 364 of the Bankruptcy Code, (B) Use Cash Collateral, (II) Granting Liens and Superpriority Administrative Expense Status, (III) Granting Adewquate Protection, (IV) Modifying the Automatic Stay, (V) Scheduling a Final Hearing, and (VI) Granting Related Relief. (Braunstein, Alan). |
Filing 9 Chapter 11 or Chapter 9 Cases Non-Individual: List of Creditors Who Have 20 Largest Unsecured Claims Against You and Are Not Insiders filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 8 Declaration Re: Electronic Filing (Re: #1 Voluntary Petition (Chapter 11), #7 20 Largest Unsecured Creditors) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 7 DISREGARD. Chapter 11 or Chapter 9 Cases Non-Individual: List of Creditors Who Have 20 Largest Unsecured Claims Against You and Are Not Insiders filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) Corrective Entry: Disregard. Incorrect Document. Modified on 4/21/2025 (ag). |
Filing 6 Motion filed by Debtor Arch Therapeutics, Inc. for Joint Administration with Case # 25-40410. (Braunstein, Alan) |
Filing 5 Application filed by Debtor Arch Therapeutics, Inc. to Employ Alan L. Braunstein, Esq., as Counsel filed with Affidavit. (Braunstein, Alan) |
Filing 4 Affidavit of Terrence Norchi (Re: #1 Voluntary Petition (Chapter 11), #3 Motion to Refinance/Incur Debt/Obtain Credit) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 3 Expedited Motion filed by Debtor Arch Therapeutics, Inc. to Obtain Credit Under Section 364 Obtain Postpetition Secured Financing Pursuant to Section 364 and Granting Liens and Superpriority Administrative Expense with Vivex Biologics, Inc.. (Braunstein, Alan) |
Filing 2 Statement Corporate Ownership Statement (Rule 7007.1) filed by Debtor Arch Therapeutics, Inc. (Braunstein, Alan) |
Filing 1 Chapter 11 Voluntary Petition Non-Individual. All Schedules and Statements and Matrix.. Filing Fee in the Amount of $1738 Filed by Arch Therapeutics, Inc.. (Braunstein, Alan) |
Receipt of filing fee for Voluntary Petition (Chapter 11)(# 25-40409) [misc,volp11] (1738.00). Receipt Number A20926393, amount $1738.00 (re: Doc#1) (U.S. Treasury) |
Search for this case: Arch Therapeutics, Inc. | |
---|---|
Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
Debtor: Arch Therapeutics, Inc. | |
Represented By: | Alan L. Braunstein |
Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
U.s. trustee: Richard King | |
Represented By: | Lisa D. Tingue |
Represented By: | Stephen E. Meunier |
Represented By: | Eric K. Bradford |
Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.